Translation and Psychometric Validation of an Italian Version of the Dance Functional Outcome Survey DFOS-IT
Launched by ANGELA CONTRI · Apr 16, 2019
Trial Information
Current as of May 12, 2025
Completed
Keywords
ClinConnect Summary
The DFOS is a dance-specific, lower extremity and low back functional outcome measure, the first and only existing at the moment.
The DFOS-IT questionnaire will be developed involving forward-backward translation, a final re-evaluation made by a representative multidisciplinary expert committee and the realization of a prefinal version to establish a proper correspondence with the original English latest version.
A factor analysis and analyses of internal consistency, construct validity, internal responsiveness and sensitivity will be conducted. The reliability will be measured for intern...
Gender
ALL
Eligibility criteria
- For all dancers, inclusion criteria :
- • A minimum of 3 years of dance training (classical, contemporary, modern-jazz ..)
- • An Intermediate to expert skill level
- • 18 years of age or older
- For healthy dancers subgroup, inclusion criteria:
- • - No low back or lower extremity injury in the previous 3 months.
- For injured dancers subgroup, inclusion criteria:
- • - at least one low back or lower extremity injury in the previous 3 months.
- For all dancers exclusion criteria:
- • Non-Italian speaking
- • Pregnancy
- • Current active disease processes other from a musculoskeletal injury in the low back or lower extremity.
About Angela Contri
Angela Contri is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes. With a focus on innovative therapies and evidence-based practices, the organization collaborates with leading healthcare professionals and research institutions to design and conduct rigorous clinical trials. Angela Contri prioritizes ethical standards, patient safety, and scientific integrity, ensuring that all studies adhere to regulatory guidelines and best practices. Through its comprehensive approach, the sponsor aims to contribute valuable insights to the medical community and facilitate the development of effective treatments for diverse health conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bologna, Bo, Italy
Patients applied
Trial Officials
Paolo Pillastrini, PT, MSc
Study Chair
University of Bologna
Giorgio Breda, PT, OMT
Study Director
University of Bologna
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials